Is Intuitive Surgical Stock a Buy?

Intuitive Surgical (NASDAQ: ISRG) capped off a record-breaking 2024 with a blowout fourth-quarter earnings report. For the period ended Dec. 31, the medical technologies (medtech) giant delivered adjusted earnings per share (EPS) of $2.21, well above the $1.79 consensus Wall Street estimate. The $2.4 billion in quarterly revenue solidly beat expectations of $2.25 billion, up 25% year over year.Despite the impressive headline numbers, the stock sold off on the report as the initial market reaction likely focused on some relatively muted guidance. Nevertheless, shareholders can't complain too much as the stock is still up about 55% over the past year.Taking into account the company's latest update, the question remains: Can the rally keep going in 2025? Let's discuss whether Intuitive Surgical stock is a buy now.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool